{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:49:02Z","timestamp":1760982542327},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.nucmedbio.2007.12.004","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T05:50:57Z","timestamp":1205905857000},"page":"335-341","source":"Crossref","is-referenced-by-count":11,"title":["Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans"],"prefix":"10.1016","volume":"35","author":[{"given":"Jo Ann V.","family":"Antenor-Dorsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Markham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Moerlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom O.","family":"Videen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2007.12.004_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0024-3205(77)90111-4","article-title":"Alterations in dopaminergic receptors in Huntington's disease","volume":"21","author":"Reisine","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/273059a0","article-title":"Receptor basis for dopaminergic supersensitivity in Parkinson's disease","volume":"273","author":"Lee","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mds.870080303","article-title":"Dopamine receptors in the basal ganglia: relevance to Parkinson's disease","volume":"8","author":"Strange","year":"1993","journal-title":"Mov Disord"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","article-title":"Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain","volume":"196","author":"Burt","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(78)91740-3","article-title":"Increased dopamine-receptor sensitivity in schizophrenia","volume":"2","author":"Owen","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/274897a0","article-title":"Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains","volume":"274","author":"Lee","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1523\/JNEUROSCI.17-02-00843.1997","article-title":"Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia","volume":"17","author":"Perlmutter","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0024-3205(77)90514-8","article-title":"Neurotransmitter receptor alterations in Parkinson's disease","volume":"21","author":"Reisine","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib9","series-title":"Brain dopaminergic systems: imaging with positron emission tomography","first-page":"5","year":"1991"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0024-3205(87)90321-3","article-title":"In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors","volume":"40","author":"Frost","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00253446","article-title":"PET measurement of D2 and S2 receptor binding of 3-N-[(2\u2032-18F]fluoroethyl)spiperone in baboon brain","volume":"14","author":"Coenen","year":"1988","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1523\/JNEUROSCI.11-05-01381.1991","article-title":"Non-steady state measurement of in vivo radioligand binding with positron emission tomography: comparison with in vitro binding","volume":"11","author":"Perlmutter","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.890030113","article-title":"Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain","volume":"3","author":"Seeman","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.890130407","article-title":"Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels","volume":"13","author":"Dewey","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.npp.1300916","article-title":"Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans","volume":"31","author":"Riccardi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib16","series-title":"Martindale the extra pharmacopeia","first-page":"567","year":"1993"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib17","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib18","first-page":"1878","article-title":"Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET","volume":"27","author":"Arnett","year":"1986","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00256924","article-title":"Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography","volume":"12","author":"Moerlein","year":"1986","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib20","first-page":"2015","article-title":"In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol","volume":"31","author":"Suehiro","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3940(92)90813-M","article-title":"Specific binding of 3N-(2\u2032-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET","volume":"148","author":"Moerlein","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0969-8051(95)00022-P","article-title":"Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand","volume":"22","author":"Moerlein","year":"1995","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00004647-199708000-00002","article-title":"In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding","volume":"17","author":"Moerlein","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time\u2013activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","article-title":"Graphical analysis of PET data applied to reversible and irreversible tracers","volume":"27","author":"Logan","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0883-2889(92)90155-8","article-title":"Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding","volume":"43","author":"Moerlein","year":"1992","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jlcr.2580221114","article-title":"A remote system for the routine production of oxygen-15 radiopharmaceuticals","volume":"22","author":"Welch","year":"1985","journal-title":"J Lab Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1109\/42.108583","article-title":"Physical characteristics of the ECAT 953B\/31: a new high resolution brain positron tomograph","volume":"10","author":"Mazoyer","year":"1991","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1088\/0031-9155\/37\/8\/002","article-title":"Physical performance of a positron tomograph for brain imaging with retractable septa","volume":"37","author":"Spinks","year":"1992","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1088\/0031-9155\/41\/1\/012","article-title":"Model-based scatter correction for fully 3D PET","volume":"41","author":"Ollinger","year":"1996","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/jcbfm.1987.85","article-title":"Cerebral blood volume measured with inhaled C15O and positron emission tomography","volume":"7","author":"Martin","year":"1987","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib33","first-page":"790","article-title":"Brain blood flow measured with intravenous H215O. II. Implementation and validation","volume":"24","author":"Raichle","year":"1983","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/jcbfm.1987.97","article-title":"Brain blood volume, flow and oxygen utilization measured with O-15 radiotracers and positron emission tomography: revised metabolic computations","volume":"7","author":"Videen","year":"1987","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00004728-199207000-00024","article-title":"Rapid automated algorithm for aligning and reslicing PET images","volume":"16","author":"Woods","year":"1992","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s002590050258","article-title":"How to obtain high-accuracy image registration: application to movement correction of dynamic positron emission tomography data","volume":"25","author":"Andersson","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004728-199307000-00004","article-title":"MRI-PET registration with automated algorithm","volume":"14","author":"Woods","year":"1993","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/jcbfm.1986.29","article-title":"Strategies for in vivo measurement of receptor binding using positron emission tomography","volume":"6","author":"Perlmutter","year":"1986","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib40","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00004647-200007000-00011","article-title":"Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions","volume":"20","author":"Parsey","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib41","first-page":"338","article-title":"Quantitative analysis of (\u2212)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates","volume":"45","author":"Hwang","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib42","first-page":"964","article-title":"Parametric mapping of binding in human brain of D2 receptor ligands of different affinities","volume":"46","author":"Siessmeier","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004647-200202000-00012","article-title":"Modified regression model for the Logan plot","volume":"22","author":"Varga","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.73.5.517","article-title":"Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging","volume":"73","author":"Ghaemi","year":"2002","journal-title":"J Neuro Neurosurg Psych"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib45","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00415-003-0188-z","article-title":"Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease. A [11C]-raclopride PET study","volume":"250","author":"Thobois","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00259-004-1465-5","article-title":"The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism","volume":"31","author":"Schreckenberger","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib47","first-page":"65","article-title":"Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a Comparative PET study with [11C]raclopride and [11C]N-methylspiperone","volume":"41","author":"Kaasinen","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib49","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00004647-200210000-00015","article-title":"Strategies to improve neuroreceptor parameter estimation by linear regression analysis","volume":"22","author":"Ichise","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004647-200004000-00002","article-title":"Analysis of four dopaminergic tracers kinetics using two different tissue input function methods","volume":"20","author":"Sossi","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02985569","article-title":"Use of reference tissue models for quantification of histamine H1 receptors in human brain by using positron emission tomography and [11c]doxepin","volume":"19","author":"Suzuki","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.12.004_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0969-8051(97)00042-5","article-title":"Radiation dosimetry of [18F](N-methyl) benperidol as determined by whole-body PET imaging of primates","volume":"24","author":"Moerlein","year":"1997","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:58:47Z","timestamp":1557385127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805108000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0969805108000024"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.12.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}